Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Alfred Sorbello
S Christopher Jones
Debra Birnkrant
Gerald Dal Pan

Showing results (1-10 of 115) with videos related to

Pageof 12
Sort By:
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|September 14, 2012
Reply to Ison et AlAlfred Sorbello, S Christopher Jones, Debra Birnkrant, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|April 12, 2012
Emergency use authorization for intravenous peramivir: evaluation of safety in the treatment of hospitalized patients infected with 2009 H1N1 influenza A virusAlfred Sorbello, S Christopher Jones, Wendy Carter, et al.
Drug Safety|September 2, 2011
Fluoroquinolone-associated myasthenia gravis exacerbation: evaluation of postmarketing reports from the US FDA adverse event reporting system and a literature reviewS Christopher Jones, Alfred Sorbello, Robert M Boucher
Pharmacoepidemiology and Drug Safety|August 22, 2013
US-based emergency department visits for fluoroquinolone-associated hypersensitivity reactionsS Christopher Jones, Daniel S Budnitz, Alfred Sorbello, et al.
The New England Journal of Medicine|December 28, 2019
Gender Parity in Clinical PrEP TrialsJeffrey Murray, Debra Birnkrant
The New England Journal of Medicine|November 4, 2009
The Emergency Use Authorization of peramivir for treatment of 2009 H1N1 influenzaDebra Birnkrant, Edward Cox
Drug Safety|May 17, 2022
"Artificial Intelligence" for Pharmacovigilance: Ready for Prime Time?Robert Ball, Gerald Dal Pan
Hepatology (Baltimore, Md.)|May 9, 2015
Direct-acting antiviral drug approvals for treatment of chronic hepatitis C virus infection: Scientific and regulatory approaches to clinical trial designsPoonam Mishra, Jeffrey Murray, Debra Birnkrant
The New England Journal of Medicine|February 26, 2010
The FDA and safe use of long-acting beta-agonists in the treatment of asthmaBadrul A Chowdhury, Gerald Dal Pan
The New England Journal of Medicine|June 7, 2018
Assessing Drug Safety in Children - The Role of Real-World DataAnn W McMahon, Gerald Dal Pan
Pageof 12

Showing results (1-10 of 115) with videos related to

Sort By:
Pageof 12
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|September 14, 2012
Reply to Ison et AlAlfred Sorbello, S Christopher Jones, Debra Birnkrant, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|April 12, 2012
Emergency use authorization for intravenous peramivir: evaluation of safety in the treatment of hospitalized patients infected with 2009 H1N1 influenza A virusAlfred Sorbello, S Christopher Jones, Wendy Carter, et al.
Drug Safety|September 2, 2011
Fluoroquinolone-associated myasthenia gravis exacerbation: evaluation of postmarketing reports from the US FDA adverse event reporting system and a literature reviewS Christopher Jones, Alfred Sorbello, Robert M Boucher
Pharmacoepidemiology and Drug Safety|August 22, 2013
US-based emergency department visits for fluoroquinolone-associated hypersensitivity reactionsS Christopher Jones, Daniel S Budnitz, Alfred Sorbello, et al.
The New England Journal of Medicine|December 28, 2019
Gender Parity in Clinical PrEP TrialsJeffrey Murray, Debra Birnkrant
The New England Journal of Medicine|November 4, 2009
The Emergency Use Authorization of peramivir for treatment of 2009 H1N1 influenzaDebra Birnkrant, Edward Cox
Drug Safety|May 17, 2022
"Artificial Intelligence" for Pharmacovigilance: Ready for Prime Time?Robert Ball, Gerald Dal Pan
Hepatology (Baltimore, Md.)|May 9, 2015
Direct-acting antiviral drug approvals for treatment of chronic hepatitis C virus infection: Scientific and regulatory approaches to clinical trial designsPoonam Mishra, Jeffrey Murray, Debra Birnkrant
The New England Journal of Medicine|February 26, 2010
The FDA and safe use of long-acting beta-agonists in the treatment of asthmaBadrul A Chowdhury, Gerald Dal Pan
The New England Journal of Medicine|June 7, 2018
Assessing Drug Safety in Children - The Role of Real-World DataAnn W McMahon, Gerald Dal Pan
Pageof 12